Jan 11, 2013 (Talk of the Nation) — To develop more effective treatments for cancer, doctors are zeroing in on the disease's genetic drivers. John DiPersio, chief of oncology at Washington University Medical Center, and Merck's Gary Gilliland discuss how this may revolutionize the future of cancer treatment.
This text will be replaced
GuestsJohn DiPersio, Chief, Division of Oncology, Washington University School of Medicine, Barnes-Jewish Hospital Deputy Director, Siteman Cancer Center, St. Louis, Missouri Gary Gilliland, Senior Vice President and Global Head of Oncology, Merck & Co., North Wales, Pennsylvania
Missing some content? Check the source: NPR
Copyright(c) 2013, NPR